New target structure for antidepressants on the horizon?

April 27, 2011
Depressive patients carrying the risk allele show volume reduction in certain regions of the hippocampus. Credit: MPI for Psychiatry

German scientists from the Max Planck Institute for Psychiatry in Munich have compared the genomes of a total of 4,088 patients and 11,001 healthy control subjects from all over the world and identified a new risk gene variant for depression.

They were able to show for the first time that physiologically measurable changes can be observed in the brains of healthy carriers of this risk allele. These changes affect a transporter protein involved in the production of an important neuronal transmitter. Given that traditional drugs interact with similar transporter molecules, the researchers are pinning great hopes on this factor as the target structure of future .Scientists throughout the world have been trying to identify the genetic causes of depression for many years.

The fact that a search of this nature can involve exciting detective work is confirmed by Martin Kohli, Susanne Lucae, Bertram Müller-Myhsok and Elisabeth Binder in their current study. When comparing the genetic material of depressive patients with that of healthy control subjects, the researchers struck gold in a particular region on chromosome 12: they discovered individual base exchanges, so-called single-nucleotide polymorphisms (SNP), which clearly arose in the context of . The researchers were very disappointed, however, when they had to establish that this section on the chromosome does not contain any . "Instead of getting our hands on a 'depression gene', we found ourselves back in a 'genetic desert' so to speak," Florian Holsboer, Director of the Max Planck Institute for in Munich, explains.

Hence, the scientists wondered whether a gene located further away could possibly be influenced by the genetic variation and whether a susceptibility for depression could arise that way. The SLC6A15 gene was identified as a promising candidate for such a link. SLC6A15 contains the construction manual for a protein, which transports amino acids like proline and leucine to the contact sites of neurons in the brain, known as synapses, and may therefore be involved in the regulation of glutamate, an important neurotransmitter found in neurons. Leucine is a structural precursor of glutamate. "Because it is assumed that the communication between the neuron clusters is disturbed in depression, we considered whether the gene we had identified could possibly influence this process through glutamate," explains Elisabeth Binder, research group leader at the MPI.

Indeed, the Max Planck scientists have succeeded in demonstrating that the changes in the DNA sequence located a total of 287,000 bases away from the gene influenced its activity: this varied in the brain samples examined, depending on which DNA components were exchanged. Therefore, cells of the risk genotype displayed a lower level of gene activity than cells carrying the protective genotype. Moreover, tests carried out by Philipp Sämann and his colleagues using the magnetic resonance imaging scanner confirmed that even healthy subjects who are carriers of the risk allele have smaller amounts of the brain metabolic substances N-acetylaspartate (NAA) and glutamate (Glx) compared to healthy subjects without genetic susceptibility.

Morphological changes also arise in the course of major depression: a shrinking of certain brain regions can eventually be observed in depressive patients. Therefore, in addition to genetic susceptibility, other factors must affect the organism to trigger the development of major depression. Research on the effects of stress as an important environmental factor in the development of depression has been carried out for many years at the Max Planck Institute for Psychiatry. It has been found, for example, that the likelihood of developing the disease increases by a factor of two to three if a person is exposed to chronic social stress.

In this context, an observation of Mathias Schmidt is of particular interest: he noted that the SLC6A15 activity in the brains of mice with an increased susceptibility to stress is considerably lower than in the brains of animals which are more resilient to stress. Irrespective of the associated cause and consequence, these data document the fact that there is a direct link between the examined gene and stress processing. "We would now like to find out how the gene converts stress into an activity-dependent cellular reaction and influences the disease process," explains the young scientist and head of a Max Planck research group. The dependency of this gene activity on chronic stress provides impressive proof of the link between genetic and environmental influences at the molecular level in the disease process. Florian Holsboer firmly believes that "the detailed study of this stress-related gene regulation will give us a new understanding of the emergence of depression."

Based on this discovery of the link between the transporter protein SCL6A15 and depression, the Munich scientists are cautiously optimistic that they are one step closer to the development of a new type of antidepressant. It has already been shown that tricyclic can bind to a related transporter in bacteria and block its activity in this way. The extent to which the characteristics of the human SLC6A15 transporter can be influenced by small molecules and, based on this, an antidepressive effect can be generated is already being investigated by a new research project at the Max Planck Institute for Psychiatry.

More information: The neuronal transporter gene SLC6A15 confers risk to major depression, Neuron (28 April 2011), D-10-00052R2

Related Stories

Recommended for you

Scientists discover common obesity and diabetes drug reduces rise in brain pressure

August 23, 2017
Research led by the University of Birmingham, published today in Science Translational Medicine, has discovered that a drug commonly used to treat patients with either obesity or Type II diabetes could be used as a novel ...

Use of brain-computer interface, virtual avatar could help people with gait disabilities

August 23, 2017
Researchers from the University of Houston have shown for the first time that the use of a brain-computer interface augmented with a virtual walking avatar can control gait, suggesting the protocol may help patients recover ...

Researcher working to develop new tool for non-invasive neuromodulation of human brain

August 23, 2017
A UTA researcher is developing a technology that will map and image the effects of infrared light shone on the human brain that may be able to modulate and improve brain waves and circuits at certain spots in the brain.

Physicist reports binary marker of preclinical and clinical Alzheimer's disease

August 23, 2017
A new technique shows high potential for providing a discrete, non-invasive biomarker of Alzheimer's disease (AD) at the individual level during both preclinical and clinical stages. The proposed biomarker has a large effect ...

Firing of neurons changes the cells that insulate them

August 22, 2017
Through their pattern of firing, neurons influence the behavior of the cells that upon maturation will provide insulation of neuronal axons, according to a new study publishing 22 August in the open access journal PLOS Biology ...

Activating brain region creates intense desire to use cocaine

August 22, 2017
Researchers have identified a portion of the brain that intensifies one's desire for certain rewards—in this case, mimicking addiction to cocaine.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.